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Introduction

45
Animal and human studies have linked prenatal exposure to environmental chemicals to 46 adverse health effects both at birth (e.g. preterm birth, low birth weight, and birth defects) and 47 later in life (e.g., neurodevelopmental defects, cancer, and cardiovascular disease). 1, 2 Previous 48 research using National Health and Nutrition Examination Survey (NHANES) data found that 49 pregnant women in the U.S. are exposed to numerous harmful manufactured chemicals, such as 50 polychlorinated biphenyls (PCBs), organochlorine pesticides (OCPs), perfluorinated compounds 51 (PFCs), industrial phenols, polybrominated diphenyl ethers (PBDEs), phthalates, and 52 perchlorate. 3 Many of these chemicals were detected in greater than 99% of U.S. pregnant 53 women. 3 Maternal exposures are of concern because many chemicals can cross the placenta to 54 reach the fetal system 4 and put the uniquely susceptible developing fetus 5,6 at risk for adverse 55 health outcomes. Health risks from simultaneous exposures to multiple chemicals are also of 56 increasing concern, as co-exposures can have interactive adverse effects. 7 57
Various factors can influence the extent to which chemicals enter the fetal environment, 58 including chemical structure, protein-binding affinity, lipophilicity, and placental permeability. 4 
59
A recent review concluded that chemical concentrations in umbilical cord blood are generally 60 lower than or equal to those in maternal blood, except in the cases of some brominated flame 61 retardants, polycyclic aromatic hydrocarbons, magnesium, and mercury (Hg), for which they are 62 consistently higher in the fetus. 8 However, estimates of maternal-to-fetal transfer efficiency 63 varied widely across studies, often spanning an order of magnitude or more for the same 64 chemical. The majority of studies reviewed also did not analyze maternal and fetal samples on a 65 pair-wise basis, limiting the ability to assess inter-individual variability in transfer efficiency. 66
The goal of this study was to better characterize prenatal exposures to multiple 67 environmental chemicals among urban, primarily Latina women -a growing and important 68 population that is not well represented in larger biomonitoring studies such as NHANES -and to 69 characterize individual variability in the transfer of chemicals between mother and fetus. We Demographic information was collected following recruitment and prior to delivery via 94 interviewer-administered questionnaire. Maternal blood was collected during labor and delivery 95 and umbilical cord blood after delivery and prior to umbilical cord clamping whenever possible. 96
Blood was collected in ethylenediaminetetraacetic acid (EDTA)-coated tubes and stored at -20°C 97 until analyzed for metals. Blood was also collected in tubes without additives and, within 24 98 hours, serum was separated by allowing clotting at room temperature, then centrifuging twice at 99 2000 rpm and transferring serum to amber glass vials for storage at -20°C until analysis for 100 persistent organic pollutants (POPs). 101 7 102   We analyzed maternal and cord blood samples for 59 analytes: 15 PCBs, 7 OCPs, 19  103 PBDEs, 4 hydroxylated PBDEs (OH-PBDEs), and 11 PFCs in serum and 3 metals in whole 104 blood (see Supporting Information for a full list of chemicals). Chemical analyses were 105 conducted at the Biomonitoring California laboratories as described below. Method detection 106 limits (MDLs) were defined as three times the standard deviation of the blank samples for 107 persistent organic analytes in serum samples. For metal analysis, MDLs were defined as 3.14 108 times the standard deviation of archived blood specimens with known low-level of analytes. 109
Chemical Analysis
PCBs, OCPs and PBDEs
110
Our analytical method using gas chromatography/high resolution mass spectrometry 111 (GC-HRMS) was previously published 9,10 and used in the current study with slight 112 modifications. Thawed serum samples (2 mL) were spiked with carbon-labeled surrogate 113 standards: nine 13 C-labeled PCBs ( 13 C 12 -PCB-101, -105, 118, -138, -153, -156, -170, -180, and -114 194); seven 13 C-labeled OCPs ( 13 C 12 -2,4′-DDT, 13 C 12 -4,4′-DDE, 13 C 12 -4,4′-DDT, 13 C 6 -115 hexachlorobenzene, 13 C 10 -oxychlordane, 13 C 10 -trans-nonachlor, and 13 C 6 -b-116 hexachlorocyclohexane [HCH]); and nine 13 C-labeled PBDEs ( 13 C 12 -BDE-28, -47, -99, -153, -117 154, -183, -197, -207, and -209). Equal volumes (4 mL) of formic acid and water were added to 118 each sample before loading on the solid phase extraction (SPE) modules (RapidTrace, Biotage ® , 119 USA). Oasis HLB cartridges (3 cc, 500 mg, Waters, Inc. USA) and acidified silica (500 o C pre-120 baked, manually packed, 3 cc) were used for the sample extraction and clean-up, respectively. 121
The collected final eluates were concentrated and spiked with recovery standard ( 13 C 12 -PCB-122 209). NIST standard reference material 1589a and bovine serum pre-spiked with known amounts 123 8 of target analytes were used as quality assurance/quality control (QA/QC) samples. Blank 124 samples (10 times diluted bovine serum) were also processed with each batch of samples. 125 9 Human serum pre-spiked with known amounts of target analytes were used as QC 144 materials (low, medium and high) were processed with each batch of samples. Method and 145 solvent blank samples were also processed with each batch and no OH-PBDEs were detected. 146
PFCs
147
We used an online SPE high-performance liquid chromatography tandem MS (SPE-148 HPLC-MS/MS) method. 12 Briefly, 100 µL of serum were mixed with 0.1M formic acid, and 149 internal standards were added ( 13 C 2 -perfluorooctanoic acid [PFOA] and 13 C 4 -perflucorooctane 150 sulfonic acid [PFOS]), then injected by the online Symbiosis TM SPE-HPLC system (Symbiosis 151 TM Pharma system with Mistral CS Cool, IChrom Inc.) to a C18 cartridge (HySphere C18 HD, 152 7 µm, 10 mm × 2 mm). After washing, the target analytes were eluted to a C8 HPLC column 153 (BETASIL C8 column, Thermo Fisher Scientific) for separation. The eluate was then introduced 154 to the MS/MS (API 4000 QTrap, ABSciex) for multiple-reaction-monitoring (MRM) analysis. 155
Analytes were quantified using a calibration curve constructed for each batch: regression 156 coefficients of 0.98 to 0.99 were generally obtained.
10
We analyzed whole blood specimens for total Hg, cadmium (Cd), and lead (Pb), using an 166 Agilent 7500cx inductively coupled plasma mass spectrometry system with a helium collision 167 cell (Agilent Technologies, Inc., Folsom, CA). 13 Blood specimens were diluted 1:50 prior to 168 analysis with a diluent comprised of 4% w/v of n-butanol, 2% w/v of NH4OH, 0.1% w/v Triton 169 X-100 and 0.1% w/v of H4EDTA to minimize blood matrix effects. Intermediate calibration 170 standards were prepared from stock standard solutions traceable to the NIST. 171
Specimen concentrations were determined using calibration curves established during 172 each analytical run, with regression coefficients ≥ 0.998 for each analyte. Each specimen was 173 analyzed in duplicate and the final result was calculated by averaging the two. Acceptance 174 criteria were based on the relative percent difference (RPD) between the two specimens. The 175 average result was deemed acceptable if the RPD was ≤20%. Fewer than 1% of the reported 176 samples had RPDs >20% due to issues with sample clotting, especially with cord blood 177 specimens. RPDs for these exceptions were <35%, and the average RPDs for Cd, Pb and Hg 178 were 11.3%, 3.7% and 6.4%, respectively. RPDs were not considered when analytical values 179 were below the MDL. Values were only reported for specimens with concentrations above the 180 MDLs, and for specimens with analyte values below MDL levels, these were reported as <MDL. 181 QC reference materials were prepared by spiking defibrinated sheep blood obtained from 182
Hemostat Laboratories (Dixon, CA, USA) with stock standard solutions at three concentrations 183 (low, medium and high). All reference materials were analyzed at both the beginning and end of 184 each batch analysis. Four concentrations of NIST standard reference material 955c were 185 periodically analyzed throughout the study to assure independent confirmation. In addition, 186 method blanks were checked daily for any detectable levels of the analytes of interest. We found that 30 chemicals were detected in at least 20 out of 65 paired maternal 232 samples ( Table 1) . Among these 30 chemicals, the probability of a chemical's detection in 233 umbilical cord serum or blood, given detection in its maternal pair, ranged from 8 to 73% for 234 PCBs, 7 to 100% for OCPs, 0 to 68% for PBDEs, 46 to 88% for OH-PBDEs, 81 to 100% for 235 PFCs, and 0 to 100% for metals ( Table 1) . Eighteen (60%) and nine (30%) of these 30 chemicals 236 had conditional probabilities ≥ 50% and ≥ 90%, respectively ( Table 1 ). Conditional probabilities 237 of detection in umbilical cord blood samples were higher for hydrophilic (median=90%) than 238 lipophilic (median=40%) chemicals (Wilcoxon rank-sum p-value=0.004). 239
We found that lipid-adjusted and wet-weight chemical concentrations in umbilical cord 240 samples were positively correlated at p<0.05 with those in maternal samples for 23 (77%) of the 241 30 chemicals detected in at least 20 paired maternal samples (Table 1 ). Statistically significant 242 correlation coefficients ranged from 0.40 to 0.93. The mean correlation coefficient was highest 243 for metals (excluding Cd), then PFCs > OCPs > OH-PBDEs > PBDEs (excluding 244 2,2',3,3',4,4',5,5',6,6'-deca-bromodiphenyl ether [BDE-197]) > PCBs. Twenty one (70%) and six 245 (20%) of these 30 chemicals had correlation coefficients > 0.5 and > 0. 8, respectively. 246 Correlations between chemical concentrations in maternal and umbilical cord samples were 247 higher for hydrophilic (median ρ=0.79) than lipophilic (median ρ=0.53 on a lipid-adjusted basis, 248 ρ=0.56 on a wet-weight basis) chemicals (Wilcoxon rank sum p-value=0.04). We also observed 249 statistically significant correlation between maternal and cord concentrations of several 250 chemicals that were not detected in at least 20 paired maternal samples, including PCBs, PBDEs, 251 2,4'-and 4,4'-dichlorodiphenyltrichloroethane (DDT), and perfluorodecanoic acid (PFDeA), 252 with coefficients ranging between 0.26 and 0.72 (see Supporting Information Table S4 ). 253
14
We found that ratios between chemical concentrations in paired maternal and cord 254 samples varied by chemical class (Table 2, Figure 2 ). For lipophilic compounds, ratios varied by 255 whether they were calculated on a lipid-adjusted or wet-weight basis (Figure 2A) . On a wet-256 weight basis, we found that median ratios of lipophilic compounds were typically lower than 257 one, with median ratios ranging between 0.2 and 0.5 for PCBs; 0.1 and 0.6 for OCPs; and 0.2 258 and 0.4 for PBDEs (Table 2) . Median ratios on a lipid-adjusted basis were between 0.7 and 1.4 259 for PCBs; 0.9 and 1.8 for OCPs; and 0.5 and 1.3 for PBDEs (Table 2) (Table 2) . 271
Individual-level variation in transfer efficiency, assessed using the GCV, tended to 272 increase somewhat with an increase in the degree of halogenation for PCBs, OCPs, and 273 carboxylate PFCs (Table 2 ). The median GCVs was lower for hydrophilic chemicals (median 274 GCV=58) than lipophilic chemicals (median GCV=74 on a lipid-adjusted basis, GCV=71 on a 275 wet-weight basis) but the differences were not statistically significant at p< 0.10. 276 15 Substituting observations < MDL with MDL/√2 generally resulted in slightly higher 277 median cord:maternal ratios and GCVs on both a wet-weight and lipid-adjusted basis (see 278
Supporting Information). 279
Discussion
280
To our knowledge, this is the first study to measure nearly 60 environmental chemicals in 281 matched maternal and umbilical cord blood samples in the U.S. We found widespread exposures 282 to a mixture of different chemicals in this primarily Latina and largely low-income population. 283
All but 12 (21%) of the 56 chemicals detected in maternal blood samples were also detected in 284 umbilical cord blood samples, indicating that they passed through the placenta and entered the 285 fetal environment, and we observed statistically significant and moderate-to-strong correlation 286 between maternal and umbilical cord concentrations for the majority (77%) of chemicals 287 detected in at least 20 paired maternal samples. Further, we found that concentrations of four 288 chemicals (the PBDE metabolite 5-OH-BDE-47, the PFCs PFOSA and 2-(N-ethyl-289 perfluorooctane sulfonamido) acetic acid [N-EtFOSAA], and Hg), were more often higher in 290 umbilical cord serum or blood than in maternal samples from the same woman (i.e., the median 291 cord:maternal concentration ratios were greater than one). Median cord:maternal concentration 292 ratios also exceeded one for many lipophilic compounds (PCB-118, -138 and -153, 4,4′-DDE, 293 HCB, and BDE-28 and -47) when ratios were calculated on a lipid-adjusted basis. 294
Chemical concentrations in maternal blood samples from our study population were 295 generally lower than those measured in a study of pregnant women in the U.S. derived from 296 NHANES 3 although our sample included more extreme observations (higher 95 th percentiles) for 297 4,4′-DDE, BDE-47 and BDE-99, and PFNA (See Supporting Information Table S3 ). Lower In general, we found much higher estimates of maternal-fetal transfer (cord:maternal 313 ratios) for lipophilic compounds (PCBs, OCPs, and PBDEs) when ratios were calculated on a 314 lipid-adjusted rather than a wet-weight basis. This is due to the fact that the umbilical cord blood 315 had lower concentrations of lipids than maternal blood, consistent with previous studies. 23, 24 If 316 one assumes body burden equilibrium in which lipid-adjusted serum measurements correspond 317 to concentrations in adipose tissue of the mother and fetus, comparisons on a lipid-adjusted basis 318 are appropriate. However, if certain chemical exposures are themselves associated with higher 319 lipid concentrations in blood, 25 then this may complicate the underlying relationship between 320 maternal-fetal transfer of chemicals and lipid adjustment may be less appropriate. 26 compared to PCBs and other polychlorinated organic compounds and hypothesized that a unique 333 transplacental transfer mechanism related to the structural similarity of PBDEs to thyroid 334 hormone may account for this difference. 29 However, we did not find evidence that trans-335 placental transfer of PBDEs was markedly higher than those of PCBs or OCPs. Our findings are 336 consistent with the majority of previous studies finding lower transfer of lower brominated 337 PBDEs relative to higher brominated PBDEs, 30-33 although this also has not been found in all 338 studies. 29, 34 Our estimates of transfer efficiency of the OCPs 4,4′-DDE, HCB, and b-HCH are 339 similar to those of a previous study conducted in Mexico. 35 
340
Although we measured generally lower concentrations of PFCs than previous studies of 341 maternal and cord serum, 24,36,37 our cord:maternal concentration ratios for PFOA and PFNA were 342 consistent with those studies. Our finding that cord:maternal concentration ratios decreased with 343 the increasing chain length of the perfluoroalkyl carboxylates is also consistent with one 344 18 previous study of PFOA (C-8), PFNA (C-9) and perfluorodecanoic acid (PFDA [C-10]). 36 We 345 observed higher cord:maternal ratios for PFOS than were found in previous studies. 24,36,37 346 Transfer efficiency appears to be higher for more branched isomers of both PFOA and PFOS, 36 347 but we did not differentiate isomers in our study so we were unable to ascertain whether 348 differences in branching may explain the higher transfer efficiency we observed for PFOS. We 349 found that PFOSA and N-Et-FOSAA had slightly higher transfer efficiencies than other PFCs, 350 which to our knowledge has not been documented before. 351
Cadmium was detected in 83% of maternal samples in this study, but not in any cord 352 blood samples, although MDLs were the same. This is consistent with prior research indicating 353 that the placenta serves as a partial barrier for Cd, perhaps through metallothiopein binding, 38,39 354 although some studies have detected Cd in cord blood. 8 Strong correlations between cord and 355 maternal concentrations of Hg and Pb were observed in this study, similar to past work, 8 and 356 provides further evidence that concentrations in maternal blood taken at delivery are a good 357 measure of relative fetal exposures to Pb and Hg at delivery. 358
Chemical concentrations were determined using blood samples taken at delivery. It is 359 possible that maternal:cord correlations and ratios vary throughout pregnancy due to changes in 360 body mass index (BMI), plasma volume expansion (PVE), lipid transfer, bone mobilization, and 361 behavioral factors. Previous research found an inverse relationship between weight gain during 362 pregnancy and concentrations of POPs in pregnant women. 40 Other studies indicate that plasma 363 volume during pregnancy progressively increases until 30-34 weeks gestation, when it reaches a 364 plateau. This process may dilute chemical concentrations of metals in blood, 41 although there has 365 been no systematic review of the evidence of such dilution. There is also a redistribution of lipids 366 from mother to fetus during the last trimester of pregnancy, 34,42 which could result in greater fetal 367 19 exposure to lipophilic compounds during the latter part of pregnancy. We were not able to assess 368 the impact of BMI, PVE or lipid transfer on our maternal and neonatal exposure estimates due to 369 a lack of data on these measures. 370
We used nonparametric methods to obtain unbiased estimates of correlation and central 371 tendency in the presence of missing values below the MDL. This results in estimates of transfer 372 efficiency that are conservative because they are conditional on detection in the maternal sample 373 and in some cases omit cord/maternal pairs where chemicals were detected in cord samples but 374 not in maternal samples (see Supporting Information Table S5 for the higher estimates that result 375 from the substitution of missing values with the MDL/√2, which allows for the inclusion of these 376 pairs). Alternate approaches to analyzing left-censored data include discarding missing values, 377 the substitution of missing values with a fixed value, maximum likelihood estimate (MLE), and 378 multiple imputation. Omitting censored observations discards valuable information (i.e. that 379 missing observations are known to be below the MDL) and leads to biased estimates of central 380 tendency. 43 Substitution with a fixed value is problematic because the unobserved values are 381 likely to be of various concentrations below the MDL. MLE and multiple imputation are 382 sensitive to assumptions about the underlying distribution of the data. They are generally not 383 recommended when working with less than 50 uncensored observations because of the difficulty 384 of assessing whether the assumed distribution is reasonable. 43 385 Our analysis did not examine the potential health consequences of chemical exposures. 386
While human studies have examined health effects for individual congeners or groups of 387 congeners of the compounds we studied, to our knowledge, no human studies have examined the 388 potentially adverse developmental and reproductive health effects of simultaneous exposures to 389 multiple chemicals in utero, which can have greater risks compared to individual exposures, 390 20 particularly for the same adverse health endpoint. 44 Exposures to many of the chemicals we 391 measured are known to affect similar endpoints, such as maternal thyroid hormone disruption 392 (e.g., PCBs and PBDEs) 45 
